title: Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy.
authors.forename: Zeydin
authors.initials: Z
authors.lastname: Acar
authors.forename: Abdurrahman
authors.initials: A
authors.lastname: Kale
authors.forename: Mehmet
authors.initials: M
authors.lastname: Turgut
authors.forename: Sabri
authors.initials: S
authors.lastname: Demircan
authors.forename: Kenan
authors.initials: K
authors.lastname: Durna
authors.forename: Serdar
authors.initials: S
authors.lastname: Demir
authors.forename: Murat
authors.initials: M
authors.lastname: Meriç
authors.forename: Mustafa Tarık
authors.initials: MT
authors.lastname: Ağaç
mesh_terms: D000328:Adult; D000368:Aged; D018943:Anthracyclines / Q000009:adverse effects*; D000069059:Atorvastatin; D009202:Cardiomyopathies / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018943:Anthracyclines; D002316:Cardiotonic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin